Ery-tab Tablet, Delayed Release
Product Images NDC 24338-122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ery-tab (NDC 24338-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Arbor Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ery Tab 01)

Chemical Structure (Ery Tab 01)
Chemical structure of erythromycin, the active ingredient in ERY-TAB delayed-release tablets by Arbor Pharmaceuticals. The diagram shows the molecular arrangement including hydroxyl, methyl, and ether groups characteristic of erythromycin.*
FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Principal Display Panel (250 mg Tablet Bottle Label)
Label for ERY-TAB 250 mg delayed-release erythromycin tablets by Arbor Pharmaceuticals. The label states 30 tablets in the package, enteric-coated and containing 250 mg erythromycin as the free base per tablet. It includes storage instructions, dispensing advice, and advises users to see the package insert for full prescribing information.*
FDA Label Image

Principal Display Panel (333 mg Tablet Bottle Label)

Principal Display Panel (333 mg Tablet Bottle Label)
Label for ERY-TAB delayed-release tablets, containing 333 mg erythromycin as the free base. Each bottle contains 30 tablets. The label specifies storage instructions, dispensing in a USP tight container, and notes the tablets are enteric-coated. The product is manufactured by Arbor Pharmaceuticals, Inc.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
ERY-TAB 500 mg delayed-release tablets label showing 30 tablets per bottle. The label indicates erythromycin as the active ingredient in delayed-release, enteric-coated tablet form. It includes storage instructions, dispensing warnings, the labeler Arbor Pharmaceuticals, Inc., and the NDC 24338-126-03 barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.